Lufenuron

(for veterinary information only)

BRAND NAME: PROGRAM and included in SENTINEL

AVAILABLE AS              
ORAL SUSPENSION          
AND IN                     
45 mg, 90 mg, 204.9 mg, & 409.8 mg
TABLETS.                    
ALSO AVAILABLE AS         
INJECTABLE for CATS         
and is included in              
SENTINEL HEARTWORM     
PREVENTATIVE for DOGS      

BACKGROUND

The U.S. market had been long in search of a flea product that was safe, convenient, and effective and many companies were racing to bring out their new product first. Ciba Animal Health (now renamed Novartis Animal Health) won this battle in 1995 with the approval of Program for use in U.S. pets. Their product had already been in use for 5 years in some 35 other countries and the U.S. welcomed this product with open arms. This medication was first licensed as a prescription drug, meaning that an animal had to have a legal patient/doctor relationship with the veterinarian in order to obtain it; however, in January of 1997, Program gained over-the-counter status. In April 1998, an injectable form became available for cats.

Novartis Animal Health feels strongly that in order to use Program effectively some understanding of how it works is needed, thus they will only distribute their product through licensed veterinarians.

HOW THIS MEDICATION WORKS

Insects are protected in the world by a hard exoskeleton made of a material called chitin. Lufenuron, Program's active ingredient, inhibits the production of chitin in insects.

By the time a flea has reached adulthood and is taking blood meals from a pet, it has made all the chitin it needs and is not directly affected by the lufenuron it is drinking in the pet's blood. The female flea, however, is largely drinking blood to support egg-laying (up to 40 eggs daily) and the larvae developing inside these eggs must make chitin in order to chip their way out of the egg. If the mother flea has passed along a healthy dose of lufenuron to her larvae, they will not be able to hatch.

Adult fleas feeding on a pet will be continually producing the black specks of digested blood called flea dirt. This material is highly nutritious for larvae developing in the environment but if this flea dirt is packed with lufenuron, the larvae will not be able to grow normal exoskeletons and they will die.

The injectable formula for cats was designed as an alternative to the relatively unpopular oral liquid. Like the oral product, injectable lufenuron is stored in body fat. One injection is effective for 6 months.

Fleas are not the only organisms to contain chitin. Apparently some fungi also are affected by lufenuron. An
"anti-ringworm" dose, which is much higher than the flea preventive dose, has been published to aid in the treatment of dermatophytosis (more commonly known as "ringworm.") The efficacy of lufenuron for fungal diseases has not panned out, however, and this unapproved use of lufenuron should be considered as an adjunct to more traditional therapies. Lufenuron should not be used as a sole therapy for ringworm.

SIDE EFFECTS

Oral lufenuron must be given on a full stomach in order to be properly absorbed into the body.

Since Program works on enzymes systems that are unique to insects, no other side effects have been reported even in animals fed hundreds of times the recommended dose.

INTERACTIONS WITH OTHER DRUGS

Program does not interact with other medications. Program is therefore compatible with all other treatments.

It is important to note that with the advent of popular top-spot treatments for fleas, special attention should be paid to the development of resistance to these products. Experience with other insects tells us that resistance can develop in 12 to 15 generations. In order to preserve these new insecticides, it is important to consider what is called integrated pest management. What this means is that insecticides should be rotated or combined with insect development inhibitors such as lufenuron or insect growth regulators like methoprene. Fleas that are resistant to the top-spot treatments must not be allowed to pass on their genes for resistance. Lufenuron (Program) ideally should be used in combination with any of the popular effective topicals.

To see a comparison of popular effective topical flea products click here.

CONCERNS AND CAUTIONS

In order for lufenuron to work, fleas must bite the pet, potentially a problem for the flea allergic pet. For pets with flea bite allergy, lufenuron would best be combined with a product that actually kills fleas. There is at present no flea product that can kill fleas before they bite.

Lufenuron must be given on a full stomach.

Pets must be at least 6 weeks of age to begin taking lufenuron.

For more information see the Program web site provided by Novartis:

www.program.novartis.us
(use links on left hand side of page for appropritate version of Program)

Page last updated: 2/27/08